When allegations of widespread fraud rocked Outcome and its clients 18 months ago, the industry started writing the company’s obituary. But new, more rigorous auditing procedures and a devotion to repairing strained relationships have combined to make Outcome the year’s most fascinating redemption story.
Merck’s Celeste Warren explains why diversity and inclusion is good for business
Celeste Warren, Merck’s diversity head, explains why D&I is good for business and shares the conversation with CEO Ken Frazier that led her to take her current post.
AI is touted as an accelerant to clinical research but has pharma embraced it?
In a few short years, programmatic buying and selling has turned the health-media world upside down. Is there still a place for traditional strategists amid the algorithms?
From SXSW: An actually interesting panel on digital health; A huge health crisis in the making